Option chain shows key data for Innovent Biologics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Innovent Biologics.

Innovent Biologics (OTC:IVBXF) Stock, Option Chain

Innovent Biologics, or Innovent, is one of the leading biotechnology companies in China. Listed on the Hong Kong Exchange in 2018, Innovent has 12 commercialized oncology products and three commercialized nononcology products as of March 2025. Its core asset is Tyvyt, a PD-1 inhibitor included in the National Reimbursement Drug Lists for the first-line treatment of five major cancers. Innovent has over 30 strategic collaborations with global pharmaceutical or biotech companies, such as Eli Lilly, Roche Group, Incyte, and others. It also has a wide spectrum of therapeutic targets in early clinical developments. Among its upcoming pipelines, the potential blockbuster is Mazdutide, a therapy for obesity and type 2 diabetes.

Biotech

Large Cap

News

Penny Stocks

Health Care

Contracts

General

INNOVENT BIOLOGICS INC by Innovent Biologics Inc.

IVBXF

Sanofi, Innovent Biologics Collaborate On Cancer Treatments In China

Government

Financing

Offerings

Small Cap

ABBV

AMRX

BNTX

BYSI

CMRX

GMAB

GMTX

INMB

MRSN

PTGX

REGN

TRVI

VALN

Here&#39;s a roundup of top developments in the biotech space over the last 24 hours:

The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron&#39;s COVID-19 Therapy Decision Pushed, Protagonist&#39;s Rusfertide Breakthrough Tag Update And More

BGNE

BTAI

CCCC

CTXR

INCY

IOVA

KNTPF

LBPH

RLMD

SRRK

STSA

Here&#39;s a roundup of top developments in the biotech space over the last 24 hours.

The Daily Biotech Pulse: BioXcel&#39;s Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy

Innovent Biologics Inc

Innovent Biologics

Comments

Innovent Biologics

Innovent Biologics (IVBXF) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell